Goede antiresistentie-maatregelen farmaceut moet concurrent inspireren
NOS takes a look at the Antimicrobial Resistance Benchmark and the current TB landscape in the Netherlands.
Date
23 January 2018
This article focuses on the topic of antibiotic resistance in the Netherlands. It highlights the findings of the Antimicrobial Resistance Benchmark relating to pharmaceutical company activities in R&D, in antibiotic manufacturing, in AMR surveillance and responsible promotion.